Cardax Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
222.40
35.70
323.40
158.40
2,236.80
243.80
Total Accounts Receivable
-
-
-
-
37.20
157.10
Inventories
986.70
958.60
-
10.80
340.40
1,480.40
Other Current Assets
108.60
112.70
90.20
142.80
113.70
143.10
Total Current Assets
1,317.70
1,107.00
413.70
312.10
2,728.20
2,024.40
Net Property, Plant & Equipment
26.00
20.60
13.90
7.80
1.90
-
Intangible Assets
424.80
419.50
424.50
430.80
426.60
434.50
Total Assets
1,768.50
1,547.10
852.10
750.60
3,156.70
2,458.90
ST Debt & Current Portion LT Debt
9,039.40
-
-
-
-
Accounts Payable
682.30
642.00
-
657.10
583.40
Other Current Liabilities
4,972.80
4,119.50
4,600.00
3,979.00
3,978.80
Total Current Liabilities
14,694.60
4,761.50
4,600.00
4,636.10
4,562.20
Other Liabilities
10.00
-
-
-
-
Total Liabilities
14,704.60
4,761.50
4,600.00
4,636.10
4,562.20
Common Equity (Total)
12,996.50
3,214.40
3,747.90
3,885.50
1,405.50
Total Shareholders' Equity
12,936.10
3,214.40
3,747.90
3,885.50
1,405.50
Total Equity
12,936.10
3,214.40
3,747.90
3,885.50
1,405.50
Liabilities & Shareholders' Equity
1,768.50
1,547.10
852.10
750.60
3,156.70
Preferred Stock (Carrying Value)
60.40
-
-
-
-

About Cardax

View Profile
Address
2800 Woodlawn Drive
Honolulu Hawaii 96822
United States
Employees -
Website http://www.cardaxpharma.com
Updated 07/08/2019
Cardax, Inc. is a life sciences company, which engages in the development, marketing, and distribution of consumer health products. It focuses on astaxanthin, which is a powerful and safe naturally occurring anti-inflammatory without the side effects of currently marketed anti-inflammatories. The company was founded on February 7, 2014 and is headquartered in Honolulu, HI.